Clinical trial
Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate…
NCT00456989 · University of Louisville, Other · Completed
Key facts
| NCT number | NCT00456989 |
|---|---|
| Title | Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer |
| Official title | Phase I/II Study of Docetaxel (Taxotere) in Combination With Doxorubicin HCI Liposome Injection (Doxil) in Advanced Androgen-Independent Prostate Cancer (AIPC) |
| Lead sponsor | University of Louisville, Other |
| Collaborators | James Graham Brown Cancer Center |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Taxotere, Doxil |
| Enrollment | 39 |
| Start date | Jan 1, 2004 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Apr 5, 2007 |
| Last update posted | Oct 30, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: